Knowledge Hub

Immunization with PCV reduced the risk of pneumococcal pneumonia in HIV-positive adults in Kenya

Prior to the introduction of PCV, adults with HIV in a rural area of Kenya were nearly five times more likely to have pneumococcal pneumonia than non-infected adults, and the majority of cases with bacteremia (blood infection) occurred in HIV positive individuals.

Full Citation:
Bigogo GM, Audi A, Auko J et al.. 2019. Indirect effects of 10-Valent pneumococcal conjugate vaccine against adult pneumococcal pneumonia in rural western Kenya. Clinical Infectious Diseases. 69(12).

Title of Article: Indirect effects of 10-Valent pneumococcal conjugate vaccine against adult pneumococcal pneumonia in rural western Kenya

Author(s): Bigogo GM, Audi A, Auko J et al.

Publication Year: 2019

Publication Name: Clinical Infectious Diseases

Publication Volume: 69(12)

Publication Source URL: https://www.ncbi.nlm.nih.gov/pubmed/30785189

DOI (Digital Object Identifier): 10.1093/cid/ciz139

Topics: Health

Disease Vaccines: Pneumococcal disease/PCV/PPSV | Pneumonia

Immunization Terms: Herd effects | HIV

Countries: Kenya

WHO Regions: Africa